ArticleAIDS and behavior2022
HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.
Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Article
- Reshaping addiction harm reduction program in Iran: The Ministry of Health's journey from reactive measures to strategic optimization.Harm reduction journal · 2026Article
- HIV testing trend and associated factors among people who inject drugs in Iran (2010-2020).Harm reduction journal · 2026Article
- Interest in HIV pre-exposure prophylaxis use and associated factors among people who inject drugs in Iran: a nationwide survey in 2023.Scientific reports · 2026Article
- HIV and syphilis seroprevalence and related unsafe sexual behaviours among people who inject drugs in Georgia: a cross-sectional study.BMJ open · 2025Article
- Programmatic mapping and size estimation of people who inject drugs to plan targeted HIV prevention and harm reduction programs in iran, a nationwide study.BMC public health · 2025Article
- Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran.Harm reduction journal · 2025Article
- Methamphetamine use and associated factors among people who inject drugs in Iran 2020.Substance abuse treatment, prevention, and policy · 2025Article
- Correlates of duration between initial drug use and first drug injection among people who inject drugs in Iran, 2020.BMC public health · 2025Article
- Prevalence and predictors of condom use among people who inject drugs in Georgia.Harm reduction journal · 2025Article
- Strengths and Weaknesses of HIV Partner Notification Implementation in Iran.AIDS and behavior · 2025Article
- Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.Harm reduction journal · 2024Article
- Sleep quality and associated factors among people who inject drugs in Iran: a nationwide survey using respondent-driven sampling.BMC public health · 2024Article
- Characterizing people who inject drugs with no history of opioid agonist therapy uptake in Iran: Results from a national bio-behavioural surveillance survey in 2020.International journal of mental health and addiction · 2024Article
- Prevalence and predictors of condom use among people who inject drugs in Georgia.Research square · 2024Article
- Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.Substance abuse treatment, prevention, and policy · 2023Article
- Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.Harm reduction journal · 2023Article
- An Evolving HIV Epidemic in the Middle East and North Africa (MENA) Region: A Scoping Review.International journal of environmental research and public health · 2023Article
- Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.Drug and alcohol dependence · 2023Article
- HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017.Harm reduction journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Injection drug use has been the leading route of HIV transmission in Iran. We assessed HIV prevalence, risk behaviors, and uptake of prevention services among people who inject drugs (PWID) in Iran between 2010 and 2020. We also examined the individual and environmental determinants of HIV among PWID. PWID were recruited in major cities across the country in three national bio--behavioral surveillance surveys in 2010, 2014, and 2020. Participants were tested for HIV and interviewed using a behavioral questionnaire. Between 2010 and 2020, the prevalence of HIV (15.1% to 3.5%), receptive needle sharing (25.2% to 3.9%) and unprotected sex (79.4% to 65.2%) decreased. Moreover, uptake of free needle/syringe increased (57.4% to 87.9%), while uptake of free condoms remained relatively stable across the surveys (34.3% to 32.6%). Multivariable analysis for the 2020 survey showed that a history of homelessness, incarceration, and a longer injection career significantly increased the odds of HIV seropositivity. During the past decade, HIV prevalence and drug- and sexual-related risk behaviors decreased among Iranian PWID. However, individual and structural determinants continue to drive HIV among this population. HIV prevention, diagnosis, and treatment among marginalized PWID with a history of homelessness or incarceration and those who inject drugs for a longer period, should be further prioritized in HIV care planning and resource allocation in Iran.
Indexed as
Identifiers
35195820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.